US-guided percutaneous microwave ablation of renal cell carcinoma: Intermediate-term results

Radiology

Volumn 263, Issue 3, 2012, Pages 900-908

  Yu, Jie ^a   Liang, Ping ^a   Yu, Xiao Ling ^a   Cheng, Zhi Gang ^a   Han, Zhi Yu ^a   Mu, Meng Juan ^a   Wang, Xiao Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; UREA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; HEMATURIA; HUMAN; INTESTINE INJURY; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS FREE SURVIVAL; MICROWAVE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARESTHESIA; PATIENT SAFETY; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR GROWTH; TUMOR SEEDING; TUMOR VOLUME; ULTRASONOGRAPHY GUIDED PERCUTANEOUS MICROWAVE ABLATION; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, RENAL CELL; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; GADOLINIUM DTPA; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROWAVES; MIDDLE AGED; PHOSPHOLIPIDS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SULFUR HEXAFLUORIDE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84862495798     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12111209     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66. (Pubitemid 46148091)
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44(1):7-26.
3. Permpongkosol S, Chan DY, Link RE, Jarrett TW, Kavoussi LR. Laparoscopic radical nephrectomy: long-term outcomes. J Endourol 2005;19(6):628-633. (Pubitemid 41129773)
4. McKiernan J, Yossepowitch O, Kattan MW, et al. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 2002;60(6):1003-1009. (Pubitemid 35447555)
5. Fujii Y, Komai Y, Saito K, et al. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008;72(3):598-602.
6. Kutikov A, Fossett LK, Ramchandani P, et al. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 2006;68(4):737-740. (Pubitemid 44633357)
7. Novick AC. Laparoscopic and partial nephrectomy. Clin Cancer Res 2004;10(18 Pt 2):6322S-6327S. (Pubitemid 39287486)
8. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166(1): 6-18. (Pubitemid 32565331)
9. Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 2008;19(9):1311-1320.
10. Liang P, Dong B, Yu X, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235(1):299-307. (Pubitemid 40432267)
11. Liang P, Wang Y, Zhang D, Yu X, Gao Y, Ni X. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J Urol 2008;180(3):844-848; discussion 848.
12. Carrafiello G, Mangini M, Fontana F, et al. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol 2010;33(2):367-374.
13. Castle SM, Salas N, Leveillee RJ. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up. Urology 2011;77(4):792-797.
14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174(2):323-331. (Pubitemid 30067129)
15. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009;38(3):135-143.
16. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. RadioGraphics 2005;25(Suppl 1): S69-S83. (Pubitemid 41686063)
17. Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005;236(1):132-139. (Pubitemid 40853305)
18. Yu J, Liang P, Yu X, Liu F, Chen L, Wang Y. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 2011;79(1):124-130.
19. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235(3):728-739. (Pubitemid 40695866)
20. Kuang M, Lu MD, Xie XY, et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna - experimental and clinical studies. Radiology 2007;242(3):914-924.
21. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010;116(13): 3135-3142.
22. Lyrdal D, Andersson M, Hellström M, Sternal J, Lundstam S. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: clinical results and radiological evolution during follow-up. Acta Radiol 2010;51(7):808-818.
23. Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011;77(6):1393-1397.
24. Mues AC, Okhunov Z, Haramis G, D'Agostino H, Shingleton BW, Landman J. Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses. J Endourol 2010;24(7):1097-1100.
25. Rodriguez R, Cizman Z, Hong K, Koliatsos A, Georgiades C. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Intervent Radiol 2011;34(3):573-578.
26. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008;113(10):2671-2680.
27. Chalasani V, Martinez CH, Lim D, Abdelhady M, Chin JL. Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. Can Urol Assoc J 2010;4(6):399-402.
28. Schmit GD, Atwell TD, Callstrom MR, et al. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol 2010;24(8): 1255-1262.
29. Wingo MS, Leveillee RJ. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring. J Endourol 2008;22(6):1261-1267. (Pubitemid 351913511)